Osivax CEO Hopes Vaccines Maker Can Develop Universal Flu ‘Silver Bullet’

Emerging Company Profile Regular column feature image Version 2
Osivax has a universal flu vaccine candidate in pre-clinical development • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Start-Ups & SMEs

More from Business